Production and characterization of immediate release lansoprazole pellets produced by melt pelletization

Pharmazeutische Industrie

Volumn 70, Issue 1, 2008, Pages 147-155

  Krošelj, Vesna ^a,b   Pišek, Robert ^a   Vrečer, Franc ^a  

^a Research and Development Division   (Slovenia)

^b KRKA D D   (Slovenia)

Author keywords

High shear mixer; Lansoprazole; Macrogolglycerides; Melt pelletization; Poloxamers

Indexed keywords

GELUCIRE; LANSOPRAZOLE; LUTROL; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; PARTICLE SIZE; PELLET EXTRUSION; SCANNING ELECTRON MICROSCOPY; STEREOMICROSCOPY;

EID: 39349092537     PISSN: 0031711X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ghebre-Sellassie I. Pellets: A general overview. In: Ghebre-Sellasie I, ed. Pharmaceutical Pelletization Technology. New York: Marcel Dekker; 1989. p. 1-13.
2. Schaefer T. Kristensen HG. Melt pelletization in a high shear mixer. I: Effects of process variables and binder. Acta Pharm Nord. 1992;4:133-140.
3. Pišek R. Krošelj V. Vrečer F. Comparison of direct rotor pelletization (fluid bed) and high-shear pelletization method for pellet production. Pharm Ind. 2005;67:243-248.
4. Schaefer T. Holm P. Kristensen G. Melt pelletization in a high shear mixer. II: Power consumption and granule growth. Acta Pharm Nord. 1992;4:141-148.
5. Seo A. Holm P. Kristensen HG. Schaefer T. The preparation of agglomerates containing solid dispersions of diazepam by melt granulation in a high shear mixer. Int J Pharm. 2003;259:161-171.
6. Chambin O. Jannin V. Interest of multi functional lipid excipients: Case of Gelucire 44/14. Drug Dev Ind Pharm. 2005;31:527-534.
7. Allen LV. Featured excipient: The poloxamers. Int J Pharm Comp. 2002;6:58-59.
8. Passerini N. Albertini B. Gonzales-Rodrigues ML. Cavallari C. Rodriguez L. Preparation and characterization of ibuprofen-poloxamer 188 granules obtained by melt granulation. Eur J Pharm Sci. 2002;15:71-78.
9. Barradell LB. Faulds D. McTavish D. Lansoprazole, a review if its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders. Drugs. 1992;44:225-250.
10. Kristl A. Vrečer F. Preformulation investigation of the novel proton pump inhibitor lansoprazole. Drug Dev Ind Pharm. 2000;26:781-783.
11. Tabata T. Makino T. Kikuta J. Hirai S. Kitamori N. Manufacturing method of stable enteric granules of a new antiulcer drug (lansoprazole). Drug Dev Ind Pharm. 1994;20:1661-1672.
12. Di Capua S. Shterman N. Ari-Pardo L. Itah E. Stable pharmaceutical composition comprising an acid labile drug. US 2005/0214372.
13. Sutananta W. Craig DQM. Newton JM. The effects of ageing on the thermal behaviour and mechanical properties of pharmaceutical glycerides. Int J Pharm. 1994;111:51-62.
14. Seo A. Schaefer T. Melt agglomeration with polyethylene glycol beads at low impeller speed in a high shear mixer. Eur J Pharm Biopharm. 2001;52:315-325.
15. Vrečer F. Kramar A. Sitar-Čurin A. Grčman M. Kotar-Jordan B. Study of influence of temperature and grinding on the crystalline state of lansoprazole. Farm vestn. 1997;48:242-243.
16. Al-Zehouri J. El-Subbagh HI. Al-Badr AA. Lansoprazole. In: Brittain HG, ed. Analytical profiles of drug substances and excipients. Academic Press; 2001:117-151.